Patent · US Active

Dihydroisoquinoline compound

US10647712B2 · kind B2 · utility

0Cited by

0References

26Claims

0Family size

Assignee

SUZHOU ARK BIOPHARMACEUTICAL CO., LTD. · CN

Inventors

Cheng PENG · Suzhou, CN
Qing Xu · South San Francisco, US
Teng Feng · Suzhou, CN
Xiashi LV · Suzhou, CN
Xiaogang LAI · Suzhou, CN
Rui Cui · Suzhou, CN
Shaoyun ZHANG · Suzhou, CN
Jian HAN · Suzhou, CN
Chaojun GONG · Suzhou, CN
Zhaoxiong Cai · Suzhou, CN
Yang Zhou · Suzhou, CN
Gang ZOU · Suzhou, CN
Danbin LI · Suzhou, CN
Haiqing Yuan · Irvine, US
Zhen Jim WU · Suzhou, CN

Key dates

Filing date	Jan 10, 2018
Grant date	May 12, 2020
Priority date	—
Expiry date	Jan 10, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of general formula I: is disclosed. The compound be used to prevent or treat hepatitis B virus infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.